Published Date：Jan. 2021
Industry：Pharma & Healthcare
Pages：113 Table Number：134
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Psychedelic Drugs market in this environment. In terms of revenue, this research report indicated that the global Psychedelic Drugs market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Psychedelic Drugs industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The COMPASS aims at producing XX Psychedelic Drugs in 2020, with XX % production to take place in global market, The Emmes Company, LLC accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Psychedelic Drugs Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Psychedelic Drugs Market? COMPASS The Emmes Company, LLC Klarisana AstraZeneca F. Hoffmann-La Roche Ltd Dr. Reddy’s Laboratories Ltd Takeda Pharmaceutical Company Limited Pfizer Inc Mylan N.V. Merck & Co., Inc Alkermes ALLERGAN H. Lundbeck A/S ... Major Type of Psychedelic Drugs Covered in XYZResearch report: Major Depressive Disorder Resistant depression Panic disorder Post-traumatic stress disorder Opiate Addiction Others Application Segments Covered in XYZResearch Market Direct Retailers Online Pharmacies Others For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Psychedelic Drugs Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Major Depressive Disorder -Product Introduction and Major Manufacturers 1.1.2 Resistant depression -Product Introduction and Major Manufacturers 1.1.3 Panic disorder -Product Introduction and Major Manufacturers 1.1.4 Post-traumatic stress disorder -Product Introduction and Major Manufacturers 1.1.5 Opiate Addiction -Product Introduction and Major Manufacturers 1.1.6 Others -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Psychedelic Drugs Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China Psychedelic Drugs Market 3.1.1 Top Companies leading Psychedelic Drugs Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China Psychedelic Drugs Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU Psychedelic Drugs Market 3.2.1 Top Companies leading Psychedelic Drugs Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU Psychedelic Drugs Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA Psychedelic Drugs Market 3.3.1 Top Companies leading Psychedelic Drugs Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA Psychedelic Drugs Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan Psychedelic Drugs Market 3.4.1 Top Companies leading Psychedelic Drugs Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan Psychedelic Drugs Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India Psychedelic Drugs Market 3.5.1 Top Companies leading Psychedelic Drugs Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India Psychedelic Drugs Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia Psychedelic Drugs Market 3.6.1 Top Companies leading Psychedelic Drugs Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia Psychedelic Drugs Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America Psychedelic Drugs Market 3.7.1 Top Companies leading Psychedelic Drugs Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America Psychedelic Drugs Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 Psychedelic Drugs Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Psychedelic Drugs Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global Psychedelic Drugs Sales and Growth Rate (2021-2026) 5.2 Global Psychedelic Drugs Sales Value and Growth Rate (2021-2026) 6 Psychedelic Drugs Competitive Analysis 6.1 COMPASS 6.1.1 COMPASS Company Profiles 6.1.2 COMPASS Product Introduction 6.1.3 COMPASS Psychedelic Drugs Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 The Emmes Company, LLC 6.2.1 The Emmes Company, LLC Company Profiles 6.2.2 The Emmes Company, LLC Product Introduction 6.2.3 The Emmes Company, LLC Psychedelic Drugs Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 Klarisana 6.3.1 Klarisana Company Profiles 6.3.2 Klarisana Product Introduction 6.3.3 Klarisana Psychedelic Drugs Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 AstraZeneca 6.4.1 AstraZeneca Company Profiles 6.4.2 AstraZeneca Product Introduction 6.4.3 AstraZeneca Psychedelic Drugs Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 6.5 F. Hoffmann-La Roche Ltd 6.5.1 F. Hoffmann-La Roche Ltd Company Profiles 6.5.2 F. Hoffmann-La Roche Ltd Product Introduction 6.5.3 F. Hoffmann-La Roche Ltd Psychedelic Drugs Production, Revenue (2015-2020) 6.5.4 SWOT Analysis 6.6 Dr. Reddy’s Laboratories Ltd 6.6.1 Dr. Reddy’s Laboratories Ltd Company Profiles 6.6.2 Dr. Reddy’s Laboratories Ltd Product Introduction 6.6.3 Dr. Reddy’s Laboratories Ltd Psychedelic Drugs Production, Revenue (2015-2020) 6.6.4 SWOT Analysis 6.7 Takeda Pharmaceutical Company Limited 6.7.1 Takeda Pharmaceutical Company Limited Company Profiles 6.7.2 Takeda Pharmaceutical Company Limited Product Introduction 6.7.3 Takeda Pharmaceutical Company Limited Psychedelic Drugs Production, Revenue (2015-2020) 6.7.4 SWOT Analysis 6.8 Pfizer Inc 6.8.1 Pfizer Inc Company Profiles 6.8.2 Pfizer Inc Product Introduction 6.8.3 Pfizer Inc Psychedelic Drugs Production, Revenue (2015-2020) 6.8.4 SWOT Analysis 6.9 Mylan N.V. 6.9.1 Mylan N.V. Company Profiles 6.9.2 Mylan N.V. Product Introduction 6.9.3 Mylan N.V. Psychedelic Drugs Production, Revenue (2015-2020) 6.9.4 SWOT Analysis 6.10 Merck & Co., Inc 6.10.1 Merck & Co., Inc Company Profiles 6.10.2 Merck & Co., Inc Product Introduction 6.10.3 Merck & Co., Inc Psychedelic Drugs Production, Revenue (2015-2020) 6.10.4 SWOT Analysis 6.11 Alkermes 6.12 ALLERGAN 6.13 H. Lundbeck A/S 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Psychedelic Drugs Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global Psychedelic Drugs Sales (K Unit) by Type (2015-2026) Figure Global Psychedelic Drugs Sales (K Unit) and Growth Rate (2015-2026) Figure Global Psychedelic Drugs Sales Market Share (%) by Type (2019 -2020) Table Global Psychedelic Drugs Sales Value (Million USD) by Type (2015-2026) Figure Global Psychedelic Drugs Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global Psychedelic Drugs Sales Value Market Share (%) by Type (2019-2020) Table Global Psychedelic Drugs Sales (K Unit) by Application (2015-2026) Table China Psychedelic Drugs Sales (K Unit) of Major Company (2015-2020) Table China Psychedelic Drugs Sales Market Share of Major Company (2015-2020) Table China Psychedelic Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure China Psychedelic Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table China Psychedelic Drugs Sales Value Share of Major Company (2015-2020) Table China Psychedelic Drugs Price (USD/Unit), by Type (2019-2020) Table China Psychedelic Drugs Sales (Unit) by Type (2015-2026) Figure China Psychedelic Drugs Sales (Unit) by Type (2015-2026) Table EU Psychedelic Drugs Sales (K Unit) of Major Company (2015-2020) Table EU Psychedelic Drugs Sales Market Share of Major Company (2015-2020) Table EU Psychedelic Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure EU Psychedelic Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table EU Psychedelic Drugs Sales Value Share of Major Company (2015-2020) Table EU Psychedelic Drugs Price (USD/Unit), by Type (2019-2020) Table EU Psychedelic Drugs Sales (Unit) by Type (2015-2026) Figure EU Psychedelic Drugs Sales (Unit) by Type (2015-2026) Table USA Psychedelic Drugs Sales (K Unit) of Major Company (2015-2020) Table USA Psychedelic Drugs Sales Market Share of Major Company (2015-2020) Table USA Psychedelic Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure USA Psychedelic Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table USA Psychedelic Drugs Sales Value Share of Major Company (2015-2020) Table USA Psychedelic Drugs Price (USD/Unit), by Type (2019-2020) Table USA Psychedelic Drugs Sales (Unit) by Type (2015-2026) Figure USA Psychedelic Drugs Sales (Unit) by Type (2015-2026) Table Japan Psychedelic Drugs Sales (K Unit) of Major Company (2015-2020) Table Japan Psychedelic Drugs Sales Market Share of Major Company (2015-2020) Table Japan Psychedelic Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure Japan Psychedelic Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan Psychedelic Drugs Sales Value Share of Major Company (2015-2020) Table Japan Psychedelic Drugs Price (USD/Unit), by Type (2019-2020) Table Japan Psychedelic Drugs Sales (Unit) by Type (2015-2026) Figure Japan Psychedelic Drugs Sales (Unit) by Type (2015-2026) Table India Psychedelic Drugs Sales (K Unit) of Major Company (2015-2020) Table India Psychedelic Drugs Sales Market Share of Major Company (2015-2020) Table India Psychedelic Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure India Psychedelic Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table India Psychedelic Drugs Sales Value Share of Major Company (2015-2020) Table India Psychedelic Drugs Price (USD/Unit), by Type (2019-2020) Table India Psychedelic Drugs Sales (Unit) by Type (2015-2026) Figure India Psychedelic Drugs Sales (Unit) by Type (2015-2026) Table Southeast Asia Psychedelic Drugs Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia Psychedelic Drugs Sales Market Share of Major Company (2015-2020) Table Southeast Asia Psychedelic Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia Psychedelic Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia Psychedelic Drugs Sales Value Share of Major Company (2015-2020) Table Southeast Asia Psychedelic Drugs Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Psychedelic Drugs Sales (Unit) by Type (2015-2026) Figure Southeast Asia Psychedelic Drugs Sales (Unit) by Type (2015-2026) Table South America Psychedelic Drugs Sales (K Unit) of Major Company (2015-2020) Table South America Psychedelic Drugs Sales Market Share of Major Company (2015-2020) Table South America Psychedelic Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure South America Psychedelic Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table South America Psychedelic Drugs Sales Value Share of Major Company (2015-2020) Table South America Psychedelic Drugs Price (USD/Unit), by Type (2019-2020) Table South America Psychedelic Drugs Sales (Unit) by Type (2015-2026) Figure South America Psychedelic Drugs Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of Psychedelic Drugs Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Psychedelic Drugs Figure Cost Structure of Psychedelic Drugs in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global Psychedelic Drugs Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global Psychedelic Drugs Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table COMPASS Profiles Table COMPASS Psychedelic Drugs Product Introduction Table COMPASS Psychedelic Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure COMPASS SWOT Analysis Table The Emmes Company, LLC Profiles Table The Emmes Company, LLC Psychedelic Drugs Product Introduction Table The Emmes Company, LLC Psychedelic Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure The Emmes Company, LLC SWOT Analysis Table Klarisana Profiles Table Klarisana Psychedelic Drugs Product Introduction Table Klarisana Psychedelic Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Klarisana SWOT Analysis Table AstraZeneca Profiles Table AstraZeneca Psychedelic Drugs Product Introduction Table AstraZeneca Psychedelic Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure AstraZeneca SWOT Analysis Table F. Hoffmann-La Roche Ltd Profiles Table F. Hoffmann-La Roche Ltd Psychedelic Drugs Product Introduction Table F. Hoffmann-La Roche Ltd Psychedelic Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure F. Hoffmann-La Roche Ltd SWOT Analysis Table Dr. Reddy’s Laboratories Ltd Profiles Table Dr. Reddy’s Laboratories Ltd Psychedelic Drugs Product Introduction Table Dr. Reddy’s Laboratories Ltd Psychedelic Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Dr. Reddy’s Laboratories Ltd SWOT Analysis Table Takeda Pharmaceutical Company Limited Profiles Table Takeda Pharmaceutical Company Limited Psychedelic Drugs Product Introduction Table Takeda Pharmaceutical Company Limited Psychedelic Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Takeda Pharmaceutical Company Limited SWOT Analysis Table Pfizer Inc Profiles Table Pfizer Inc Psychedelic Drugs Product Introduction Table Pfizer Inc Psychedelic Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Pfizer Inc SWOT Analysis Table Mylan N.V. Profiles Table Mylan N.V. Psychedelic Drugs Product Introduction Table Mylan N.V. Psychedelic Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Mylan N.V. SWOT Analysis Table Merck & Co., Inc Profiles Table Merck & Co., Inc Psychedelic Drugs Product Introduction Table Merck & Co., Inc Psychedelic Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Merck & Co., Inc SWOT Analysis Table Alkermes Profiles Table Alkermes Psychedelic Drugs Product Introduction Table Alkermes Psychedelic Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Alkermes SWOT Analysis Table ALLERGAN Profiles Table ALLERGAN Psychedelic Drugs Product Introduction Table ALLERGAN Psychedelic Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ALLERGAN SWOT Analysis Table H. Lundbeck A/S Profiles Table H. Lundbeck A/S Psychedelic Drugs Product Introduction Table H. Lundbeck A/S Psychedelic Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
